title: Adjuvant chemotherapy and whole abdominal irradiation for gastric carcinoma.
abstract: OBJECTIVE
  To analyze the efficacy and toxicity of adjuvant chemotherapy followed by whole abdominal irradiation in the treatment of resectable gastric cancer with positive lymph nodes.
  
  
  METHODS
  Between 1996 and 1999, 10 patients with node-positive gastric cancer underwent complete gross resection and were treated by postoperative chemoradiotherapy. The chemotherapy regimen consisted of 5-fluorouracil, 1000 mg/m2/day as a 96-hr continuous infusion on day 1, and cisplatin, 100 mg/m2 on day 2, every 21 days. Six courses were planned. Radiotherapy was administered 3 weeks after completion of the chemotherapy protocol as a single-fraction dose of 600 cGy in a two-field (anterior and posterior) configuration.
  
  
  RESULTS
  Treatment was generally well tolerated, with no treatment-related deaths. However, 9 of the 10 patients died of recurrent disease, with a median survival of 20 months (range, 7-84).
  
  
  CONCLUSIONS
  Adjuvant chemotherapy with whole abdominal irradiation for gastric cancer is safe and tolerable but has no apparent effect on patient outcome. Studies in larger series are needed to evaluate the role of the approach in this disease.
authors.affiliation: Institute of Oncology Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel. yuliak@clalit.org.il
authors.forename: Yulia
authors.initials: Y
authors.lastname: Kundel
authors.forename: Mark L
authors.initials: ML
authors.lastname: Levitt
authors.forename: Bernice
authors.initials: B
authors.lastname: Oberman
authors.forename: Siegal
authors.initials: S
authors.lastname: Sadezki
authors.forename: Thomas
authors.initials: T
authors.lastname: Tichler
authors.forename: Zvi
authors.initials: Z
authors.lastname: Symon
authors.forename: Raphael
authors.initials: R
authors.lastname: Catane
authors.forename: Raphael
authors.initials: R
authors.lastname: Pfeffer
authors.forename: Baruch
authors.initials: B
authors.lastname: Brenner
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002277:Carcinoma / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D019583:Dose Fractionation, Radiation; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007262:Infusions, Intravenous; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D002945:Cisplatin; D005472:Fluorouracil